DOP2010000163A - Propionato de 3-(2,2,2-trimetilhidrazinio) del grupo de fumarato de hidrogeno y fosfato de dihidrogeno - Google Patents

Propionato de 3-(2,2,2-trimetilhidrazinio) del grupo de fumarato de hidrogeno y fosfato de dihidrogeno

Info

Publication number
DOP2010000163A
DOP2010000163A DO2010000163A DO2010000163A DOP2010000163A DO P2010000163 A DOP2010000163 A DO P2010000163A DO 2010000163 A DO2010000163 A DO 2010000163A DO 2010000163 A DO2010000163 A DO 2010000163A DO P2010000163 A DOP2010000163 A DO P2010000163A
Authority
DO
Dominican Republic
Prior art keywords
propionate
trimethylraziny
dihydrogen phosphate
phosphate group
hydrogen fumarate
Prior art date
Application number
DO2010000163A
Other languages
English (en)
Inventor
Llmars Stonans
Eduard Tararak
Elena Andreyeya
Original Assignee
Grindeks Joint Stock Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40481525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2010000163(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks Joint Stock Company filed Critical Grindeks Joint Stock Company
Publication of DOP2010000163A publication Critical patent/DOP2010000163A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

USO MEDICO NOVEDOSO DE SALES DE PROPIONATO DE 3(2,2,2-TRIMETIL HIDRAZINIO) PARA LA FABRICACION DE UN MEDICAMENTO PARA LA PREVENCION Y TERAPIA DE LA ATEROESCLEROSIS.
DO2010000163A 2007-12-04 2010-06-02 Propionato de 3-(2,2,2-trimetilhidrazinio) del grupo de fumarato de hidrogeno y fosfato de dihidrogeno DOP2010000163A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122273 2007-12-04
EP07122272 2007-12-04

Publications (1)

Publication Number Publication Date
DOP2010000163A true DOP2010000163A (es) 2010-08-31

Family

ID=40481525

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000163A DOP2010000163A (es) 2007-12-04 2010-06-02 Propionato de 3-(2,2,2-trimetilhidrazinio) del grupo de fumarato de hidrogeno y fosfato de dihidrogeno

Country Status (32)

Country Link
US (1) US20100234459A1 (es)
EP (1) EP2222293B1 (es)
JP (1) JP2011505408A (es)
KR (1) KR20100084688A (es)
CN (1) CN101951898B (es)
AR (1) AR069521A1 (es)
AT (1) ATE518536T1 (es)
AU (1) AU2008333262A1 (es)
BR (1) BRPI0819057A2 (es)
CA (1) CA2706354C (es)
CL (1) CL2008003551A1 (es)
CO (1) CO6280477A2 (es)
CY (1) CY1112336T1 (es)
DK (1) DK2222293T3 (es)
DO (1) DOP2010000163A (es)
EA (1) EA019424B1 (es)
GE (1) GEP20125673B (es)
HR (1) HRP20110744T1 (es)
IL (1) IL205961A0 (es)
MA (1) MA31993B1 (es)
MX (1) MX2010006255A (es)
MY (1) MY150508A (es)
PA (1) PA8805901A1 (es)
PE (1) PE20091037A1 (es)
PL (1) PL2222293T3 (es)
PT (1) PT2222293E (es)
RS (1) RS51992B (es)
SI (1) SI2222293T1 (es)
TN (1) TN2010000250A1 (es)
TW (1) TW200930356A (es)
WO (1) WO2009071585A1 (es)
ZA (1) ZA201003641B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425835A1 (en) * 2010-08-18 2012-03-07 Grindeks, a joint stock company A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
TWI487524B (zh) * 2010-12-03 2015-06-11 Tetra Sia 菸鹼酸和米曲肼之新穎治療組合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2535150C (en) * 2003-08-04 2010-04-13 Joint Stock Company "Grindeks" Non-hygroscopic, stable meldonium salts, method of preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CL2008003551A1 (es) 2010-01-22
GEP20125673B (en) 2012-10-25
MY150508A (en) 2014-01-30
EA019424B1 (ru) 2014-03-31
PT2222293E (pt) 2011-11-15
ZA201003641B (en) 2011-03-30
CO6280477A2 (es) 2011-05-20
CA2706354C (en) 2013-08-13
TW200930356A (en) 2009-07-16
AU2008333262A1 (en) 2009-06-11
US20100234459A1 (en) 2010-09-16
CA2706354A1 (en) 2009-06-11
JP2011505408A (ja) 2011-02-24
TN2010000250A1 (en) 2011-11-11
CN101951898B (zh) 2012-12-05
EP2222293B1 (en) 2011-08-03
EP2222293A1 (en) 2010-09-01
EA201000738A1 (ru) 2011-04-29
HRP20110744T1 (hr) 2011-11-30
WO2009071585A1 (en) 2009-06-11
CY1112336T1 (el) 2015-12-09
IL205961A0 (en) 2010-11-30
AR069521A1 (es) 2010-01-27
PL2222293T3 (pl) 2012-01-31
RS51992B (en) 2012-04-30
MA31993B1 (fr) 2011-01-03
BRPI0819057A2 (pt) 2015-05-05
DK2222293T3 (da) 2011-11-21
KR20100084688A (ko) 2010-07-27
ATE518536T1 (de) 2011-08-15
CN101951898A (zh) 2011-01-19
PE20091037A1 (es) 2009-08-19
SI2222293T1 (sl) 2011-12-30
PA8805901A1 (es) 2009-07-23
MX2010006255A (es) 2011-03-15

Similar Documents

Publication Publication Date Title
CY1116927T1 (el) Προφαρμακα της τετραϋδροκανναβινολης, συνθεσεις οι οποιες περιλαμβανουν προφαρμακα της τετραϋδροκανναβινολης και μεθοδοι χρησης των ιδιων
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
MX2009013989A (es) Terapia en combinacion para depresion.
MX2009011444A (es) Titulacion del tapentadol.
AR079208A2 (es) Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica
UY30460A1 (es) Compuestos terapéuticos
SV2011003897A (es) Tratamiento de pirfenidona para pacientes con funcion hepatica atipica
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
CR20110243A (es) Tratamiento de pirfenidona para pacientes con función hepática.
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
NO20050861L (no) Anvendelse av 1-fenyl-3-dimetylamino-propanforbindelser til terapi av depressive symtpomer
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
CO5700723A2 (es) Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca
DOP2010000163A (es) Propionato de 3-(2,2,2-trimetilhidrazinio) del grupo de fumarato de hidrogeno y fosfato de dihidrogeno
SV2010003585A (es) Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetil hidrazinio)
MX2020007627A (es) Uso de la carrimicina o de sus ingredientes activos.
TR201902863T4 (tr) Eri̇tropoi̇eti̇n ve seftri̇akson i̇çeren farmasöti̇k bi̇r bi̇leşi̇m ve parki̇nson hastaliği demansinin tedavi̇si̇ i̇çi̇n bi̇r i̇lacin üreti̇lmesi̇nde bunun bi̇r kullanimi.
UA100129C2 (ru) Применение гидрофумарата и дигидрофосфата 3-(2,2,2-триметилгидразиния) пропионата для лечения или профилактики атеросклероза
CY1112203T1 (el) Καινοτομικες θεραπευτικες χρησεις της αδρενεργικης αλφουζοσινης
CY1120669T1 (el) Συνδυαστικη θεραπεια για αγωγη σκληρυνσης κατα πλακας
TH103212A (th) การใช้ทางการแพทย์แบบใหม่ของเกลือ 3-(2,2,2-ไตรเมทิลไฮดราซิเนียม) โพรพิโอเนต
CU20080041A7 (es) Compuestos terapéuticos
UA29829U (ru) Способ лечения больных непролиферативной диабетической ретинопатией
AR062307A1 (es) Milnacipran parel tratamiento de fatigas asociadas con el sindrome de fibromalgia